In Australia eight products were approved via this initiative between July 2018 and May 2020: five oncology products (apalutamide, abemaciclib, niraparib, darolutamide and isatuximab), two for a cardiology indication (tafamidis and tafamidis meglumine) and baloxavir marboxil indicated for the treatment of influenza
These drugs have shown great promise in helping individuals lose weight effectively and sustainably
The compounded 60 mg format offers cost savings but does not carry the same regulatory oversight
In addition, gut microbiota can compete with harmful bacteria for nutrients, thereby inhibiting their growth and generating antibacterial substances that suppress the proliferation of pathogens ( Gut microbiota primarily affects the disease process through endogenous metabolites produced by gut microbiota and changes in the composition of gut microbiota
One of the most common questions online is why bacteriostatic water contains benzyl alcohol
In 2026, the average Part D deductible is $371 in MA-PDs, up 63% since 2025 ($228) and 481% since 2024 ($64) (Figure 7)